Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.
By S. Capes, D. Hunt, K. Malmberg, H. Gerstein. The Lancet, 2000
2,252 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/116117fbac57bc67b121bbbd06495423c3980ff5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Endocrinology, Diabetes and Metabolism
- V. Basevi
- J. Krinsley
- Aarti Grover
- Antonio Ceriello
- Silvio E. Inzucchi
- I. Hirsch
- K. ‐. Tseng
- M. S. Kirkman
Citations in the corpus
- Standards of Medical Care in Diabetes—2008 (2008, background): “When diabetes was present and admission glucose averaged 180 mg/dl (10 mmol/l), risk of death was moderately increased compared with patients who had diabetes but less hyperglycemia on admission (277).”
- Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview (2001, methodology): “Studies retrieved by the literature search were included in the overview if they (1) assembled and prospectively followed an inception cohort, (2) explicitly stated that blood glucose was drawn within 24 hours of admission, (3) reported follow-up of $80% to hospital discharge or to 1 month, and (4) ”
- Standards of Medical Care in Diabetes—2012 (2011, background): “When diabetes was present and admission glucose was 180 mg/dl (10 mmol/l), risk of death was moderately increased compared with patients who had diabetes but no hyperglycemia on admission (147).”
- Severe hypoglycemia in critically ill patients: Risk factors and outcomes* (2007, background): “These observations must be paired with evidence suggesting that hyperglycemia in acutely and critically ill patients may have markedly different prognostic implications for diabetics and nondiabetics; the relationship between increasing glycemic levels and mortality is much more profound among the l”
- Management of diabetes and hyperglycemia in hospitals. (2004, neutral): “(192) reported a blood glucose threshold of 109.”
- Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* (2003, background): “A few atadmission patient- and disease-related factors (body mass index, history of diabetes, reason for ICU admission, atadmission hyperglycemia) (5, 7, 16, 17), the mean daily amount of calories per kilogram of body weight, the time in ICU and concomitant medication such as glucocorticoids were ab”
- Glycemic variability: A strong independent predictor of mortality in critically ill patients* (2008, background): “Diagnostic categories include, in part, medical and surgical neurologic illness (2, 3), acute coronary syndromes (4, 5), cardiovascular surgery (6), and a variety of different intensive care unit (ICU) populations (7–9).”
- Standards of Medical Care in Diabetes–2006 (2006, background): “When diabetes was present and admission glucose 180 mg/dl (10 mmol/ l), risk of death was moderately increased compared with patients who had diabetes but no hyperglycemia on admission (196).”
- Postprandial hyperglycemia and diabetes complications: is it time to treat? (2005, background): “As far as infarction is concerned, it has been recently demonstrated by a metaanalysis that there is a continuous correlation between glucose serum levels and the seriousness of the prognosis even in nondiabetic subjects (22), while intensive insulin treatment during acute myocardial infarction redu”